Search
Single-breath washout and association with structural lungdisease in children with cystic fibrosis Abstract Background: In children with cystic
The AREST CF experience in biobanking — More than just tissues, tubes and time Abstract Research to further improve outcomes for people with CF is
CrossTalk opposing view: mucosal acidification does not drive early progressive lung disease in cystic fibrosis CrossTalk opposing view: mucosal
Early Lung Surveillance of Cystic Fibrosis: what have we learnt? Click to read the full article Authors: Rachel E Foong, Tim Rosenow, Luke W
News & Events
Boosting mums’ immunity could save newborns from deadly respiratory virusesPerth respiratory researchers have discovered that giving an immune booster to mothers during pregnancy could increase their newborns’ resistance to severe and life-threatening respiratory viral infections.
News & Events
Seven innovative lung health research projects supported by Wal-yan Centre fundingSeven innovative lung health research projects have received funding support as the 2023 Wal-yan Respiratory Research Centre Strategic Inspiration Projects.
News & Events
State Government grant to support development of new therapies for respiratory virusesA project to be undertaken by a team of researchers at the Wal-yan Respiratory Research Centre, led by chief investigator Professor Stephen Stick, aims to develop interventions that could provide protection in the event of a new pandemic, and against common viruses already infecting children in WA.
News & Events
Lots to celebrate as Wal-yan Respiratory Research Centre turns 2As the Wal-yan Respiratory Research Centre turns two, the Centre celebrates its achievements and thanks everyone involved in the work of the Centre.
Research
Screening Measures of Perinatal Mental Health and Wellbeing in Fathers: A Scoping ReviewAccurately screening fathers for perinatal mental health problems requires well-validated screening instruments that assess the expression of paternal perinatal mental distress. This study aimed to identify and describe the psychometric properties of perinatal mental health screening instruments administered to paternal cohorts within the past two decades.
Research
Safety, tolerability, and pharmacokinetics of a 2 g subcutaneous dose of ceftriaxone as an alternative to intravenous deliverySubcutaneous delivery of antibiotics is a practical alternative to intravenous administration. Ceftriaxone is commonly used for a variety of infections with limited data on the safety and pharmacokinetics of a 2 g subcutaneous dose. This was a prospective, self-controlled cross-over study in 20 stable inpatients receiving ceftriaxone for their infection. Following an intravenous dose, participants received a single dose of 2 g subcutaneous ceftriaxone, in 50 mL normal saline via gravity feed.